Wall Street Reporter WallStreetReporter.com

CellCube Energy Storage Systems Inc. (CSE: CUBE) (OTC: CECBF) “$100 Million Sales Pipeline 2019” Interview with CEO Mike Neylan discussing commercialization of CellCube’s vanadium redox flow batteries; energy storage business.
Hosted on Acast. See acast.com/privacy for more information.

We caught up with Paul, at the airport, to discuss Elixinol’s progress in the CBD and hemp consumer products and foods markets, which has resulted in over AUD$14 million revenues and profits in Q2 2018.
Paul also talks about the company’s business strategy, and the plans for deploying a recent AUD$40 million capital raise, to expand global sales growth.

Hosted on Acast. See acast.com/privacy for more information.

Medicine Man Technologies (OTC: MDCL) CEO Interview with Andy Williams, co-founder, and CEO. Andy explains what has been driving continued revenue and profitability growth, in this vertically integrated marijuana “picks and shovels” player, which offers consulting services to growers, as well as product sales. 
The company’s is growing revenues at a rapid pace: For the 9 months, ending 9/30/2018, total income increased to $9,917,476 (compared to total income of $2,585,479 in same period 2017).
Net income increased dramatically to $5,157,717 or $0.19 per share, compared to losses of ($4,868,859) or ($0.22) for the same 9 month period ending September 30, 2017.
Andy, also talks about plans for growth in 2019 and beyond, which include, expanding into marijuana cultivation, and capitalizing on M&A opportunities as the industry consolidates. 

Hosted on Acast. See acast.com/privacy for more information.

CytoDyn Inc. (OTC: CYDY) CEO Interview with Nader Pourhassan, Ph.D, discussing CytoDyn’s PRO140 monoclonal antibody therapy for HIV and cancer.
The company is at a key inflection point, with potential FDA approval for PRO140 for treating HIV expected in 2019. 
Dr. Pourhassan explains the PRO140 technology, its numerous advantages over current HIV therapies on the market, market potential, as well as expanding PRO140’s indications for treating cancer. 

Hosted on Acast. See acast.com/privacy for more information.

Cobalt27 Capital Corp. (TSX.V: KBLT) (OTC: CBLLF) interview with Anthony Milewski, Chairman & CEO.
Cobalt is a key ingredient in electric vehicle, and energy storage batteries. In this interview, Anthony explains how Cobalt27 is structured to offer investors a proxy on the rapidly growing electric vehicle and energy storage markets, via its cobalt mining royalty streams, and physical ownership of cobalt metal (which has current market value of about $200 million).
Topics discussed include:
– Overview of cobalt market
– Update on recent acquisitions
– Possibility of dividend payments, as cashflow from royalties begins in 2019
– Cobalt27’s assets located in politically stable Canada & Australia (Vs. Congo)
– Why stock is intrinsically undervalued today, and offers upside potential
– And more…

Hosted on Acast. See acast.com/privacy for more information.

NightFood Holdings, Inc. (OTC: NGTF) Interview with CEO Sean Folkson discussing progress in expanding national distribution for the company’s NightFood ice cream brand – which targets the $50 billion “late night snacking” market.
NGTF has just launched its ice cream brand, and Sean provides an update on the national distribution rollout, positive feedback from retailers, and consumers, including winning “Product of the Year” award.
Sean outlines a goal of being in 10,000 stores by next year which should drive revenues of $30-50 million, and how NGTF is following in the footsteps of other innovative ice cream brands which rapidly became billion dollar brands within a few years. 

Hosted on Acast. See acast.com/privacy for more information.